These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17638852)
1. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Shin J; Monti S; Aires DJ; Duvic M; Golub T; Jones DA; Kupper TS Blood; 2007 Oct; 110(8):3015-27. PubMed ID: 17638852 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Litvinov IV; Jones DA; Sasseville D; Kupper TS Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883 [TBL] [Abstract][Full Text] [Related]
3. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors. Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835 [TBL] [Abstract][Full Text] [Related]
4. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151 [TBL] [Abstract][Full Text] [Related]
6. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma. Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541 [TBL] [Abstract][Full Text] [Related]
7. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356 [TBL] [Abstract][Full Text] [Related]
8. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649 [TBL] [Abstract][Full Text] [Related]
9. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. Zackheim HS; Amin S; Kashani-Sabet M; McMillan A J Am Acad Dermatol; 1999 Mar; 40(3):418-25. PubMed ID: 10071312 [TBL] [Abstract][Full Text] [Related]
10. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Nevala H; Karenko L; Vakeva L; Ranki A Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. Su IJ; Tsai TF; Cheng AL; Chen CC J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539 [TBL] [Abstract][Full Text] [Related]
12. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782 [TBL] [Abstract][Full Text] [Related]
13. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas. Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200 [TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan. Takahashi Y; Takata K; Kato S; Sato Y; Asano N; Ogino T; Hashimoto K; Tashiro Y; Takeuchi S; Masunari T; Hiramatsu Y; Maeda Y; Tanimoto M; Yoshino T Cancer Sci; 2014 Jul; 105(7):912-23. PubMed ID: 24815502 [TBL] [Abstract][Full Text] [Related]
17. Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Assaf C; Hummel M; Steinhoff M; Geilen CC; Orawa H; Stein H; Orfanos CE Blood; 2005 Jan; 105(2):503-10. PubMed ID: 15459015 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses. Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393 [TBL] [Abstract][Full Text] [Related]